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Granulomas are cellular inflammations that vary widely in histologic appearance depend-
ing upon the inciting agent and immunologic status of the responding host. Despite their
heterogeneity, granulomas are at their core an ancient innate sequestration response char-
acterized by the accumulation of mononuclear phagocytes. In fact, this innate cellular
response was first observed by Metchnikov in simple invertebrates. Among higher ver-
tebrates, environmental pressures have resulted in the evolution of more sophisticated
adaptive immune responses which can be superimposed upon and modify the character
of granulomatous inflammation. Compared to immune responses that rapidly neutralize
and eliminate infectious agents, the granuloma represents a less desirable “fall back”
response which still has value to the host but can be co-opted by certain infectious agents
and contribute to bystander organ damage. Understanding granulomas requires an analy-
sis of the complex interplay of innate and adaptive molecular signals that govern the focal
accumulation and activity of their cellular components. Among these signals, small mol-
ecular weight chemoattractant proteins known as chemokines are potentially important
contributors as they participate in both directing leukocyte migration and function. This
tract will discuss the contribution of chemokines to the development of innate and adap-
tive granuloma formation, as well as describe their relationship to more recently evolved
cytokines generated during adaptive immune responses.
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INTRODUCTION
The granuloma is defined as a cellular immune response in which
the local accumulation of mononuclear phagocytes is a key com-
ponent (Warren, 1976). The aggregation of mononuclear phago-
cytes is a sequestration response likely representing one of the ear-
liest forms of innate cellular immunity. It is observed in primitive
multicellular organisms and was first documented by Elie Metch-
nikov in his studies of starfish larvae. Over the millennia more
sophisticated innate and adaptive immune responses have evolved,
supplanting, or being superimposed upon the granuloma. In mod-
ern vertebrates, granulomas have varied histologic appearances
and cellular elements depending upon the nature of the eliciting
agent and host immune status, which determine the degree of cel-
lular activity and chronicity of the response (Figure 1). In humans,
there are many granulomatous conditions indicating that this
response has persisted among the spectrum of immune responses
and may confer some benefit, but compared to modern adaptive
immune responses which can often rapidly eliminate microbes,
the granuloma may be a “fall back” response relying on sequestra-
tion and attempted elimination. However, some pathogens such
as Mycobacterium tuberculosis can co-opt the response residing
for decades within granulomas only to reemerge when adap-
tive immunity is compromised. Other undesirable features of
granulomas are chronic bystander organ damage and fibrosis.
Hence, an understanding of the mechanisms underlying gran-
uloma formation would potentially have important therapeutic
benefit.
CHEMOKINES AND CHEMOKINE RECEPTORS
A basic requirement of granuloma formation involves directed
cell migration to achieve focal cellular accumulation in response
to infection, injury, or foreign bodies. It is well established that cell
migration requires surface membrane receptors capable of recog-
nizing extracellular molecules which initiate intracellular signal
transduction events leading to selective gene expression and the
cytoskeletal reorganization required for cell movement. Directed
migration appears to depend upon cells sensing and following
molecular chemotactic gradients of increasing concentration gen-
erated in the vicinity of an inciting agent. There are many types
of chemotactic molecules but a family of homologous proteins
with conserved motifs containing four cysteine residues known as
chemokines, appear to be of particular importance. The topic of
chemokines and their receptors has been extensively reviewed so
need only a brief description herein (Zlotnik and Yoshie, 2012).
There are over 40 known human chemokine ligands (L) divided
among four classes based upon the arrangement of the amino ter-
minal cysteine residues, these are suffixed, CCL, CXCL, CX3CL,
and XCL. Most have homologs in the mouse and are produced
by a wide variety of host cells. Their carbohydrate free molecular
weight ranges from 7 to 10 kDa and they are often basically charged
molecules with heparin binding properties. Their activity is medi-
ated by seven-transmembrane domain, G protein-coupled recep-
tors. The primary receptor-binding domain of all chemokines is
near the extracellular amino terminus. Over 20 chemokine recep-
tors have been characterized. Some display promiscuous ligand
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FIGURE 1 | Potential fates of the innate granuloma. In the
immunocompetent host the ultimate type of granuloma manifested will
depend in large part on the nature of the inciting agent. Weakly antigenic
agents with poor expression of pathogen (PAMP) and or damage (DAMP)
associated molecular patterns will result in a persisting low turnover innate
granuloma. Examples would be surgical implant and suture granulomas.
Weakly antigenic agents associated with greater PAMPs or DAMPs will
activate a broader spectrum of innate responding cells resulting in more
complex higher turnover innate granulomas. Examples would be silica,
zymosan, and muramyl dipeptide induced granulomas. Strongly antigenic
agents with associated PAMP or DAMP signals will initiate additional adaptive
antigen-specific T cell responses resulting in a complex high turnover
granuloma. The types of cellular components will depend upon the
participating T cell subset. Examples would be mycobacterial, fungal, and
parasite ova elicited granulomas. It should be noted that humoral elements
including antibodies and complement may also influence lesions. Lower
panels show examples of the histologic appearance of the various
granulomas. (A) Innate low turnover foreign-body granulomatous response to
surgical bone cement; (B) Innate high turnover granulomatous response to
silica; (C) Adaptive granulomatous response to M. tuberculosis, Th1 type; (D)
Adaptive eosinophil-rich, granulomatous response to schistosome parasite
egg, Th2 type. Original magnifications 200×.
binding while others bind only a single known ligand. Recep-
tor nomenclature is determined by the class of chemokine it
binds (CCR, CXCR, CX3CR, and XCR). Receptors are differ-
entially expressed by cell populations and can change during
stages of cell maturation/activation. For example, CXCR1 and
CXCR2 are highly expressed by neutrophils permitting responses
to chemokine ligands CXCL1–8, which express the amino acid
sequence of glutamic acid-leucine-arginine (ELR) immediately
before the first cysteine of the CXC motif. In contrast, CXCR3
is expressed by effector lymphocytes and responds to CXCL9, 10,
and 11, which lack the ELR sequence. Chemokines are expressed in
a vast array of pathologic and physiologic states involving cellular
migration. Therefore a mechanistic role in granuloma formation
is a reasonable hypothesis. This tract will present a focused review
of the studies performed in our laboratory to test this hypothesis.
EXPERIMENTAL GRANULOMAMODELS
In order to study mechanisms underlying granuloma formation,
a number of animal-based experimental approaches have been
developed which model a variety of granulomatous conditions,
but due to widely varying experimental conditions it is difficult to
compare cellular and molecular events among them. To provide
a systematic experimental approach, our laboratory developed
and characterized mouse models of synchronized lung granu-
loma formation elicited by intravenous embolization of agarose
beads coupled to antigens derived from pathogens associated with
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granulomatous diseases. Hence, granulomas elicited by diverse
etiologic agents could be studied in parallel. As iconic represen-
tatives of highly prevalent granulomatous diseases, we utilized
purified protein derivative (PPD) from Mycobacterium bovis and
soluble egg antigens (SEA) derived from ova of the helminth
parasite Schistosoma mansoni. Detailed immunologic character-
ization revealed that in pre-sensitized animals, the antigen-bead
models respectively elicited polarized Th1 [interferon-γ (IFNγ)
mediated] and Th2 (interleukin -4 and -13 mediated) adaptive
hypersensitivity-type granulomas with cellular compositions sim-
ilar to those elicited by live infections (Chensue et al., 1994). As well
as being compared to each other, these adaptive responses could be
compared to those elicited in unsensitized naive mice, represent-
ing the underlying innate granulomatous response. As shown in
Figures 2 and 3, innate granulomas are smaller with comparable
cellular compositions, whereas the adaptive responses are signif-
icantly larger with the PPD response showing greater neutrophil
and NK cell component and the SEA response showing greater
eosinophil content superimposed upon the large mononuclear
infiltrate. The period of most rapid cellular recruitment occurs
from 1 to 3 days with a period of sustenance followed by resolution.
CHEMOKINE EXPRESSION PATTERNS DURING INNATE AND
ADAPTIVE GRANULOMA FORMATION
Using semiquantitative polymerase chain reaction gene expres-
sion analysis, we defined the temporal appearance of a panel
of CXCL and CCL chemokines during synchronized innate and
adaptive antigen bead-elicited granuloma formation (Chiu et al.,
2003). Lungs of mice were harvested and analyzed at inter-
vals after granuloma induction. As shown in Figure 4, both
innate and adaptive responses displayed the greatest expres-
sion of chemokines in the first 2–3 days of granuloma forma-
tion, corresponding to the period of robust cellular recruit-
ment. Despite quite different antigens, the patterns and degree
of chemokines produced during innate granuloma formation
in response to BSA, SEA, and PPD beads were very similar,
except the PPD-elicited response showed higher expression of
neutrophil chemotactins, CXCL2, CXCL5, and CCL3, which corre-
lated with greater neutrophil recruitment. This finding suggested
the presence of additional Ag-related innate recognition and was
consistent with the ability of mycobacterial PPD components
to stimulate Toll-like receptors, TLR2 and TLR4 (Means et al.,
2001).
FIGURE 2 | Synchronized innate and adaptive antigen bead-elicited
pulmonary granuloma formation. (A) Histologic appearance and sizes of
innate antigen bead granulomas. Agarose beads covalently bound to
Mycobacterium bovis purified protein derivative (PPD), Schistosoma mansoni
soluble egg antigens (SEA), or bovine serum albumin (BSA), (CON) were
administered intravenously to naïve C57BL/6 mice at a dose of 6000 beads
per mouse. Lungs were harvested at the designated time points for histologic
examination and cross-sectional measurement using computer assisted
image analysis. A minimum of 20 lesions were measured. Dashed line
represents average bead size. (B) Histologic appearance and sizes of adaptive
antigen bead granulomas. Antigen beads were administered as above, but
mice were pre-sensitized to the respective mycobacterial and schistosome
egg antigens. Lungs were harvested at the designated time points for
histologic examination and cross-sectional measurement as above. Size of a
non-antigen coated control bead reaction is shown in chart for comparison.
Bars are means and standard deviations of five mice.
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FIGURE 3 | Cellular composition of innate and adaptive antigen
bead-elicited pulmonary granulomas. (A) Time course of major cell
populations recruited during adaptive and innate granuloma induction. Innate
BSA and adaptive PPD- and SEA-antigen bead lung granulomas were elicited
as described in Figure 2. On the indicated days, granulomas were harvested
and enzymatically dispersed, washed, and then used for differential analysis.
(B) Day 4 cell composition of innate and adaptive PPD- and SEA-antigen bead
granulomas. Granulomas were elicited and harvested as above and then
washed cellular suspensions were subjected to differential analysis to
determine cellular components. Lymphocytes (Lymp), large mononuclear
cells (Large mono), eosinophils (Eos), and neutrophils (Neu) were determined
by standard morphologic analysis. Flow cytometry was used to identify
lymphoid subpopulations CD4+ and CD8+T cells, natural killer (NK+). Bars
are means and standard deviations of five mice.
During adaptive granuloma formation, polarization of the
mycobacterial and helminth antigen bead-elicited chemokine pro-
files became clearly apparent. During PPD-bead elicited gran-
uloma formation the CXCL chemokines dominated with levels
increasing up to 10-fold over the innate response. In contrast,
during the SEA response these remained at innate levels. Among
the CCL chemokines, there was amplification of most but with
a lesser degree of polarization. However, the SEA-bead elicited
response displayed augmented CCL7 expression whereas the PPD
response remained at innate levels. CCL7 is a ligand for the CCR3
receptor expressed by eosinophils which are a major component
of the adaptive granulomatous response to SEA.
CYTOKINE REGULATION OF CHEMOKINE EXPRESSION
DURING ADAPTIVE GRANULOMA FORMATION
Chemokine expression analyses of Ag-bead-elicited granuloma
formation demonstrated the presence of innate chemokine
responses which were modified by superimposition of adaptive
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FIGURE 4 | Dynamics of chemokine transcript expression during
innate and adaptive antigen bead-elicited granulomas formation.
Innate and adaptive PPD- and SEA-antigen bead granulomas were
elicited as described in Figure 2. Lungs were harvested at the
designated time points for mRNA extraction and cDNA preparation.
Chemokine transcript levels were determined by semiquantitative
real-time RT-PCR. Mean arbitrary units (AU) were derived from five to six
individual lungs per point.
immunity. Moreover, the character of the adaptive chemokine pro-
file differed depending on whether the adaptive cellular response
was either Th1- or Th2-mediated. To directly test if Th1 and
Th2-related cytokines were responsible for shaping the chemokine
patterns observed during the adaptive response, mice with either
type-1 PPD- or type-2 SEA-bead elicited adaptive granulomas
were treated with cytokine neutralizing antibodies to IFNγ, IL-12,
IL-4, IL-10, or IL-13, then chemokine transcripts were measured
on day 2, during the period of most active chemokine induction.
As summarized in Table 1, IFNγ depletion decreased a num-
ber of the transcripts during mycobacterial PPD-elicited type-1
granuloma formation, especially the CXCL chemokines. This was
associated with a significant reduction in granuloma size mea-
sured on day 4. In the helminth SEA-elicited type-2 response,
the IFNγ-dependent CXCL9–11 chemokines were also reduced
but CCL4, CCL7, CCL17, and CCL22 were increased with about
a 30% augmentation of granuloma cross-sectional area. This
demonstrated a cross-regulatory effect of endogenous IFNγ in
the type-2 response. Anti-IL-12 also reduced CXCL9-11 during
the type-1 response but with a lesser reduction in granuloma
size. Since IL-12 is an innate stage cytokine known to enhance
IFNγ, this likely represented an effect on the IL-12 dependent
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Table 1 | Effect of cytokine depletion of chemokine transcript expression and granuloma formation*.
Granuloma
type and
treatment
CXCL2 CXCL5 CXCL9 CXCL10 CXCL11 CCL1 CCL2 CCL3 CCL4 CCL7 CCL8 CCL11 CCL17 CCL22 XCL1 Effect
on lesion
area
TYPE-1 (PPD)
Anti-IFN −41%
Anti-IL-12 −14%
Anti-IL-4 ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND ND
Anti-IL-13
Anti-IL-10
TYPE-2 (SEA)
Anti-IFN +28%
Anti-IL-12
Anti-IL-4 −38%
Anti-IL-13 −30%
Anti-IL-10
*Cells shaded red indicates significant decreases; green indicates significant increases and white indicates no change. ND, not determined.
component of IFNγ production, though a direct effect could not
be ruled out. In the type-2 response, IL-12 depletion had no effect
on CXC but increased a number of the CC chemokines with-
out affecting overall inflammation, suggesting that endogenous
IL-12 has a regulatory effect but the enhanced CC chemokine
transcript expression could not further augment inflammation.
Since IFNγ depletion did reduce CXC chemokines and augmented
type-2 inflammation, it suggests a role for CXC chemokines in
recruitment or stimulation of a population that tempers type-
2 inflammation. In the type-2 response, depletion of the Th2
cytokines, IL-4, or IL-3, caused reductions of most CC with
no effect on the CXC chemokine transcripts, which was associ-
ated with significant reductions in granuloma sizes. Anti-IL-13
also reduced some CC chemokines in the type-1 PPD response
with augmentation of CXCL9-11, indicating a regulatory effect of
underlying IL-13, but no net effect on inflammation was observed.
Depletion of endogenous IL-10 which may derive from both
innate and adaptive immune cells appeared to influence only
a limited number of CC chemokines with no effect on overall
inflammation.
It should be noted that in addition to our finding of chemokine
modulation by Th1- and Th2-related cytokines, recent studies of
neutrophil-rich granulomas elicited by S. japonicum eggs show
participation of Th17 cells and IL-17 dependence of neutrophil
chemotactins, CXCL1, and CXCL2 (Zhang et al., 2012).
To summarize, cytokines appear to shape the spectrum and
degree of chemokines produced during adaptive granuloma
formation through positive and negative signaling. Polarized
cytokine responses lead to different chemokine profiles presum-
ably designed to generate a pathogen specific granulomatous
response.
CHEMOKINE CONTRIBUTION TO GRANULOMA FORMATION
Published literature demonstrates consistent circumstantial
expression of chemokines in animals models of granulomatous
conditions and human granulomatous diseases. However,
revealing their functional significance is more challenging.
Because, of their potential promiscuity in receptor-binding, exper-
iments designed to neutralize or knockout individual chemokines
leave open the possibility of compensatory or redundant
chemokines. The alternative approach is to focus on the relative
requirement of chemokine receptors, which are less numerous
than chemokines and often show restricted cellular expression.
An important aspect of chemokine receptors is their dynamic
nature. A particular cell may express different receptors at different
maturational stages as well as alter levels of expression follow-
ing activation or receptor ligation. Most studies of chemokine
receptors employ chemokine receptor knockout mouse strains
or specific receptor antagonists. We and others have used these
approaches to assess their role in granuloma formation. Those
findings are discussed below.
CCR1
CCR1 (CD191) is a highly promiscuous receptor with reported
binding to multiple CC ligands (CCL3, CCL5, CCL7, CCL8,
CCL14, CCL15, CCL16, and CCL23). It is expressed by a number
of cell types including macrophages and lymphocyte populations.
When type-1 PPD- or type-2 SEA-bead elicited adaptive granulo-
mas were elicited in CCR1 knockout (CCR1−/−) mice, there was
little effect on overall sizes of secondary lesions. However, there
were subtle but distinct effects on the type-1 response. The latter
unlike the type-2 lesion is characterized by a component of natural
killer (NK) cells, which was absent in CCR1−/− mice. In addi-
tion, there was reduced production of Th1-associated cytokines
by draining lymph node cultures (Shang et al., 2000). In a sep-
arate study, Gao et al. (2000) reported impairment neutrophil
recruitment and abrogation of the granulomatous response to
primary injection of whole S. mansoni eggs in CCR1−/− mice.
When we tested the innate granulomatous response to PPD- and
SEA-beads, we again showed impaired NK cell recruitment as
well as compromised neutrophil recruitment (Chiu et al., 2004).
Taken together, the findings suggest a role for CCR1 in the innate
response, which may partially influence the quality of subsequent
adaptive responses.
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CCR2
Like CCR1, CCR2 (CD192) is a promiscuous receptor, bind-
ing CCL2, CCL7, CCL8, CCL13, and CCL16. A wide variety of
cell types are reported to express CCR2 including monocytes,
lymphocytes, and non-leukocytic cells. When type-1 PPD- or
type-2 SEA-bead elicited adaptive granulomas were elicited in
CCR2 knockout (CCR2−/−) mice, there was impaired mono-
cyte/macrophage recruitment especially during the initial stages
of granuloma formation. In the type-1 response this was asso-
ciated with notable reductions in Th1 cytokine production by
draining lymph node cultures and while there was partial reduc-
tion of IL-4 producing capacity in the type-2 response the
Th2 cytokine profile remained largely intact (Boring et al.,
1997; Warmington et al., 1999). An analysis of innate granu-
loma formation in CCR2−/− mice similarly showed impaired
monocyte/macrophage recruitment in both PPD- and SEA-bead
elicited lesions. In addition, both showed significant reductions
in granuloma associated myeloid dendritic cells (mDCs), thus
providing a potential link between recruitment and adaptive
phase cytokine defects (Chiu et al., 2004). A similar mono-
cyte/macrophage recruitment defect has been reported in a
model of zymosan-elicited granuloma formation (Jinnouchi et al.,
2003). Together the findings suggest a critical role for CCR2
in the mobilization of the innate monocyte/macrophage and
mDC component of granulomas. The lack of which can signif-
icantly influence subsequent adaptive stage events, mainly the Th1
response.
CCR3
CCR3 (CD193) is another promiscuous receptor binding CCL3,
CCL5, CCL7, CCL11, CCL13, CCL14, CCL15, CCL24, and CCL26.
It is highly expressed by eosinophils and basophils as well as
lymphocyte subpopulations and some non-leukocytic cells. No
systematic studies of granuloma formation in CCR3 knockout
mice have been reported. However, we have tested the role of
two its ligands, CCL7 and CCL11 (eotaxin). Transcript analyses
in those studies showed induction of CCR3, CCL7, and CCL11
during both type-1 PPD- and type-2 SEA-bead elicited adaptive
granuloma formation, but expression of all was greater in the lat-
ter and augmented expression was dependent on IL-4. In vivo
CCL7 and CCL11 depletions revealed that CCL7 and not CCL11
contributed to eosinophil recruitment in the type-2 response
(Ruth et al., 1998; Shang et al., 2002). These data provided indi-
rect evidence of differential participation of CCR3 agonists and
demonstrated a role for selected chemokines in shaping granuloma
cellular composition.
CCR4
CCR4 (CD194) has two known agonist ligands CCL17 and CCL22.
The receptor is reportedly expressed by a variety of leukocytic and
non-leukocytic populations. Among T cells it has been mainly
associated with skin homing CD4+ effector memory, Th2 effec-
tor, and T regulatory cells. Constitutive expression of CCL17
and CCL22 is detectable among myeloid DCs and is upregu-
lated by inflammatory stimuli (Penna et al., 2002). As described
above, these ligands are induced during innate and adaptive type-1
PPD- and type-2 SEA-bead elicited granuloma formation. When
adaptive granulomas were elicited in CCR4 knockout (CCR4−/−)
mice, there was partial abrogation of the type-1 response and
decreased local IFNγ production. The inflammation associated
with type-2 granulomas was largely unaffected but showed reduc-
tions of local IL-5 and IL-13 production (Freeman et al., 2006).
These studies indicated that in the mouse CCR4 participation was
not restricted to Th2 dominant responses. Additional in vivo and
in vitro experiments suggested that CCR4 was required for effector
memory cell activation by mDCs. Thus, CCR4 may allow for opti-
mal contacts between effector cells and mDCs under homeostatic
and challenge conditions.
CCR5
CCR5 (CD195) is a promiscuous receptor-binding CCL4, CCL5,
CCL8, CCL11, CCL14, and CCL16 as agonists. It has been exten-
sively studied due to its ability to act a coreceptor for human
immunodeficiency virus (HIV). CCR5 is expressed on T cells,
macrophages, mDCs, and some non-leukocytic cells. Among T
cells it reportedly shows biased expression by CD4+ Th1 and
CD8+ T cells, however most reports suggest CCR5 is dispens-
able for mounting resistance to variety of pathogen challenges.
In regard to granuloma formation, we observed no effect of
CCR5 knockout on the innate response to either PPD- or SEA-
beads (Chiu et al., 2004). However, Souza et al. (2011) demon-
strated significant exacerbation of the Th2-mediated granuloma-
tous response to S. mansoni eggs. This observation would be
consistent with our finding that depletion of CCL5, a potent
agonist of CCR5, augments type-2 granuloma formation (Chen-
sue et al., 1999). Taken together, these studies suggest the pres-
ence of CCR5-dependent immunoregulation of type-2 adaptive
granuloma formation.
CCR6
Unlike other CC chemokine receptors, the gene for CCR6 (CD196)
is carried on a different chromosome (human chromosome 6,
mouse chromosome 17) than the others which are clustered
(human chromosome 3, mouse chromosome 9). It is also unique
in that it has only one known chemokine agonist ligand, CCL20.
CCR6 is expressed by mDCs, mature B cells, subpopulations of
memory/effector CD4+ and CD8+ T cells, but not plasmacy-
toid DCs or naïve T cells. Among CD4+ T cells, CCR6 has been
associated with Th1 and Th17 subpopulations. While the ligand
for CCR6 has been reported in models of granuloma formation
(Qiu et al., 2001), there are as yet no systematic functional analy-
ses. Despite its expression by immature mDCs, no defect in local
mDC recruitment was observed during the innate granuloma-
tous response to PPD- or SEA-beads elicited in CCR6 knockout
(CCR6−/−) mice (Chiu et al., 2004). In preliminary studies of
adaptive type-1 PPD- and type-2 SEA-bead elicited granuloma
formation, CCR6−/− mice displayed no defects in type-1 inflam-
mation and only a partial impairment of eosinophil recruitment
in the type-2 response. However, alterations in draining lymph
node cytokine and immunoglobulin induction events were noted
(unpublished observations). A number of studies point to a role
for CCR6 in mucosal and lymphoid tissue events (Ito et al.,
2011), hence there may be less contribution to interstitial gran-
ulomatous responses. However, CCR6-mediated effects on the
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adaptive immunity could influence some aspects of granuloma
formation.
CCR8
CCR8 (CDw198) has a limited agonist complement, CCL1,
CCL8 (mouse), CCL16, and is expressed by T cells and possibly
macrophage subsets. Among T cells it has been associated with Th2
and T regulatory populations. There are limited studies examining
the contribution of CCR8 to granuloma formation. We performed
detailed analyses of type-1 PPD- and type-2 SEA-bead elicited
adaptive granuloma formation in CCR8 knockout (CCR8−/−)
mice (Chensue et al., 2001; Freeman et al., 2005). Those stud-
ies showed the CCR8 was required for establishment of a normal
eosinophil-rich type-2 granuloma, but was not required for the
type-1 granulomatous response. The critical CCR8+ population
was identified as a CD4+ IL-10+ regulatory T cell that appeared
to enhance expression of the Th2 response likely by tempering
cross-regulatory signals.
CXCR4
CXCR4 (CD184) has one known chemokine agonist, CXCL12,
and is expressed by a variety of leukocytes including T cells as well
as non-leukocytic cells. In addition to T cell chemotaxis, CXCR4
appears to play roles in regulating stem cell homing to the bone
marrow, HIV entry into cells and tumor metastasis. Since CXCR4
knockout is lethal, we used a specific CXCR4 receptor antagonist,
AMD3465, to test its effects on type-1 PPD- and type-2 SEA-bead
elicited granuloma formation (Hu et al., 2006). CXCL12 tran-
scripts are induced locally and in draining lymph nodes upon
granuloma elicitation with the greatest expression in the adaptive
type-2 response. Accordingly, treatment had no effect on the innate
or the adaptive type-1 responses, but the type-2 adaptive response
was significantly abrogated with reductions of both eosinophils
and mononuclear phagocytes. In addition, Th2 cytokine produc-
tion by draining lymph node cultures was notably compromised.
Thus,CXCR4 showed biased participation in establishing the type-
2 adaptive granulomatous response. Precise mechanisms remain
to be determined.
CONCLUSION
Using models of synchronized innate and adaptive pulmonary
granuloma formation we have demonstrated a role for chemokines
in the development of these lesions. The emerging picture is
one in which different chemokines contribute to different stages,
components, and functional aspects of granulomas. Conceptual-
izing and classifying granulomas in terms of innate and adaptive
responses allows for more precise interpretation of cellular events.
As described above, some chemokines contribute more to the
innate component of the response whereas others are invoked by
adaptive stage molecular signals amplifying and altering granu-
loma cellular composition to provide functions needed to contain
and or eliminate an insulting agent. As major mediators of the
inflammation, chemokines are a potential target for therapeutic
manipulations to temper or optimize the granulomatous response.
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